跳至主要内容
临床试验/CTRI/2025/02/080206
CTRI/2025/02/080206尚未招募4 期

A prospective, randomized controlled trial to compare the outcomes of same day vs Day 3 discharge following cardiac implantable electronic device implantation.

Dr Duggempudi Lakshmi Narayana1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2025年2月20日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
150
试验地点
1
主要终点
The primary objective of this study is to assess the Safety,Quality of life  and Economic Impact of same-day discharge versus a standard 3-day discharge following cardiac implantable electronic device (CIED) implantation.

研究概览

简要总结

Aims to determine safety,quality of life ,economic impact between day 1 versus day 3 discharge.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • All patients eligible for CIED.

排除标准

  • Critical Complications Post-Procedure: Significant hematoma at the insertion site.
  • Lead dislodgment or repositioning issues.
  • Suspected or confirmed infection.
  • Re-Implantation Cases: Patients undergoing pacemaker replacement or upgrade to CRT/ICD.
  • Pre-Existing Severe Comorbidities: Advanced renal failure requiring dialysis.
  • Active malignancy.
  • Pregnancy: Pregnant or lactating women.
  • Non-Compliance: Patients unlikely to adhere to follow-up protocols.
  • Patients unable to comprehend study requirements or provide consent.
  • Coexistent Cardiac Complications: Severe heart failure (NYHA Class III-IV).
  • Severe valvular heart disease.
  • Participation in Other Trials: Patients enrolled in another clinical trial that could affect outcomes.

结局指标

主要结局

The primary objective of this study is to assess the Safety,Quality of life  and Economic Impact of same-day discharge versus a standard 3-day discharge following cardiac implantable electronic device (CIED) implantation.

时间窗: The primary objective of this study is to assess the Safety,Quality of life  and Economic Impact of same-day discharge versus a standard 3-day discharge following cardiac implantable electronic device (CIED) implantation. | Quality of life is assessed at the time of discharge.Safety outcomes are assessed at 6 months .Economic impact at the time of discharge.

次要结局

  • 1)Minor and Major complications at 1 month post discharge(2)Severity of Tricuspid Regurgitation at 6 months)

研究者

发起方
Dr Duggempudi Lakshmi Narayana
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Duggempudi Lakshmi Narayana

Post graduate institute of medical education and research

研究点 (1)

Loading locations...

相似试验